Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2
Juan Pablo López, Malte Lücken, Elena Brivio, et al.
Neuron (2022) Vol. 110, Iss. 14, pp. 2283-2298.e9
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

A paradigm shift in translational psychiatry through rodent neuroethology
Yair Shemesh, Alon Chen
Molecular Psychiatry (2023) Vol. 28, Iss. 3, pp. 993-1003
Open Access | Times Cited: 88
The antidepressant actions of ketamine and its enantiomers
Jenessa N. Johnston, Ioline D. Henter, Carlos A. Zarate
Pharmacology & Therapeutics (2023) Vol. 246, pp. 108431-108431
Open Access | Times Cited: 72
Arketamine, a new rapid-acting antidepressant: A historical review and future directions
Jichun Zhang, Wei Yao, Kenji Hashimoto
Neuropharmacology (2022) Vol. 218, pp. 109219-109219
Open Access | Times Cited: 69
Ketamine: Mechanisms and Relevance to Treatment of Depression
Ji‐Woon Kim, Kanzo Suzuki, Ege T. Kavalali, et al.
Annual Review of Medicine (2023) Vol. 75, Iss. 1, pp. 129-143
Closed Access | Times Cited: 51
Brain region–specific action of ketamine as a rapid antidepressant
Min Chen, Shuangshuang Ma, Hanxiao Liu, et al.
Science (2024) Vol. 385, Iss. 6709
Closed Access | Times Cited: 20
A small-molecule activation mechanism that directly opens the KCNQ2 channel
Shao-ying Zhang, Demin Ma, Kun Wang, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 7, pp. 847-856
Closed Access | Times Cited: 18
Psychedelics and Neural Plasticity: Therapeutic Implications
Steven F. Grieco, Eero Ċastrén, Gitte M. Knudsen, et al.
Journal of Neuroscience (2022) Vol. 42, Iss. 45, pp. 8439-8449
Open Access | Times Cited: 44
Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants
Tao Chen, Ling Cheng, Jingwen Ma, et al.
Pharmacological Research (2023) Vol. 194, pp. 106837-106837
Open Access | Times Cited: 23
Pharmacological inhibition of Kir4.1 evokes rapid-onset antidepressant responses
X. K. Zhou, Cheng Zhao, Haiyan Xu, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 7, pp. 857-866
Closed Access | Times Cited: 14
Introducing a depression-like syndrome for translational neuropsychiatry: a plea for taxonomical validity and improved comparability between humans and mice
Iven-Alex von Mücke-Heim, Lidia Urbina-Treviño, Joeri Bordes, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 329-340
Open Access | Times Cited: 32
Advancing social behavioral neuroscience by integrating ethology and comparative psychology methods through machine learning
Joeri Bordes, Lucas Miranda, Bertram Müller‐Myhsok, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 151, pp. 105243-105243
Open Access | Times Cited: 18
Sex-specific and opposed effects of FKBP51 in glutamatergic and GABAergic neurons: Implications for stress susceptibility and resilience
Lotte van Doeselaar, Tibor Štark, Shiladitya Mitra, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 23
Open Access | Times Cited: 17
Early life adversity shapes social subordination and cell type–specific transcriptomic patterning in the ventral hippocampus
Aron Kos, Juan Pablo López, Joeri Bordes, et al.
Science Advances (2023) Vol. 9, Iss. 48
Open Access | Times Cited: 16
An integrative view on the cell-type-specific mechanisms of ketamine's antidepressant actions
Vern Lewis, Gareth M. Rurak, Natalina Salmaso, et al.
Trends in Neurosciences (2024) Vol. 47, Iss. 3, pp. 195-208
Open Access | Times Cited: 7
Sustained antidepressant effects of ketamine metabolite involve GABAergic inhibition-mediated molecular dynamics in aPVT glutamatergic neurons
Ayako Kawatake-Kuno, Haiyan Li, Hiromichi Inaba, et al.
Neuron (2024) Vol. 112, Iss. 8, pp. 1265-1285.e10
Closed Access | Times Cited: 7
Roles of KCNA2 in Neurological Diseases: from Physiology to Pathology
Changning Xie, Miriam Kessi, Fei Yin, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 11, pp. 8491-8517
Closed Access | Times Cited: 6
Interactions Between Antidepressants and Intestinal Microbiota
Feiyu Xu, Qinglian Xie, Weihong Kuang, et al.
Neurotherapeutics (2023) Vol. 20, Iss. 2, pp. 359-371
Closed Access | Times Cited: 13
Ketamine and the Disinhibition Hypothesis: Neurotrophic Factor-Mediated Treatment of Depression
Philip Borsellino, Reese I. Krider, Deanna Chea, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 742-742
Open Access | Times Cited: 13
Esketamine mitigates endotoxin-induced hippocampal injury by regulating calcium transient and synaptic plasticity via the NF-α1/CREB pathway
Mu Xu, Jialiang Wang, Jia Shi, et al.
Neuropharmacology (2025), pp. 110362-110362
Closed Access
Sketch of a novel approach to a neural model
Gabriele Scheler
F1000Research (2025) Vol. 14, pp. 218-218
Open Access
Ketamine Alters Specific Gene Expression Profiles by Transcriptome-Wide Responses in a Ketamine-Induced Schizophrenia-Like Mouse Model
Zhe Du, Xiumei Zhu, Peng Lv, et al.
Molecular Neurobiology (2025)
Closed Access
(2R,6R)‐hydroxynorketamine prevents opioid abstinence‐related negative affect and stress‐induced reinstatement in mice
Andria Michael, Anna Onisiforou, Polymnia Georgiou, et al.
British Journal of Pharmacology (2025)
Open Access
Combined ketamine and psychotherapy provide no additional benefit beyond ketamine alone in treating depression or PTSD: Evidence from a help-seeking sample
Tyler M. Moore, Kathryn C. Walker, Elizabeth L. Tung, et al.
Journal of Affective Disorders (2025)
Closed Access
The role of hippocampal KCNQ2 channel in antidepressant actions of ketamine
Li Ma, Kenji Hashimoto
Neuron (2022) Vol. 110, Iss. 14, pp. 2201-2203
Open Access | Times Cited: 20
The Role of Glutamate Underlying Treatment-resistant Depression
Jeongseop Kim, Tae-Eun Kim, Seung‐Hwan Lee, et al.
Clinical Psychopharmacology and Neuroscience (2023) Vol. 21, Iss. 3, pp. 429-446
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top